Evaluation of cardiac function in patients with pemphigus vulgaris before and after rituximab infusion

[1]  F. Rehman,et al.  Rituximab in Pemphigus – An Observational Study from a Tertiary Care Center of North India , 2022, Indian dermatology online journal.

[2]  J. Silverberg,et al.  Association of autoimmune blistering disease, and specifically, pemphigus vulgaris, with cardiovascular disease and its risk factors: a systematic review and meta-analysis , 2022, Archives of Dermatological Research.

[3]  M. Dalamaga,et al.  Real world evidence: Patients with refractory pemphigus treated with Rituximab , 2021, Metabolism open.

[4]  Mohamed Y. Elwazir,et al.  Rituximab for the Treatment of Refractory Cardiac Sarcoidosis-A Single Center Experience. , 2021, Journal of cardiac failure.

[5]  E. Martanto,et al.  Global and Regional Longitudinal Strain Reduction in Breast Cancer Patients After First Chemotherapy Cycle With Fluorouracil, Adriamycin, and Cyclophosphamide Regimen , 2021, Cardiology research.

[6]  K. Chanprapaph,et al.  Rituximab Therapy for Treatment of Pemphigus in Southeast Asians , 2021, Drug design, development and therapy.

[7]  A. Azizpour,et al.  Adverse electrocardiographic effects of rituximab infusion in pemphigus patients , 2020, Dermatologic therapy.

[8]  M. Tabary,et al.  Cardiac function in pemphigus vulgaris patients before and after steroid pulse therapy , 2019, The Journal of dermatological treatment.

[9]  E. Oikonomou,et al.  Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-analysis. , 2019, JAMA cardiology.

[10]  S. Jensen,et al.  Echocardiographic global longitudinal strain is associated with infarct size assessed by cardiac magnetic resonance in acute myocardial infarction , 2019, Echo research and practice.

[11]  Ionut Donoiu,et al.  Longitudinal strain analysis allows the identification of subclinical deterioration of right ventricular function in patients with cancer therapy-related left ventricular dysfunction , 2019, Discoveries.

[12]  R. Abdulla,et al.  Use of Speckle Tracking Echocardiography to Assess Left Ventricular Systolic Function in Patients with Surgically Repaired Tetralogy of Fallot: Global and Segmental Assessment , 2018, Pediatric Cardiology.

[13]  S. Xavier,et al.  Global Longitudinal Strain Accuracy for Cardiotoxicity Prediction in a Cohort of Breast Cancer Patients During Anthracycline and/or Trastuzumab Treatment , 2018, Arquivos brasileiros de cardiologia.

[14]  E. Schmidt.  Rituximab as first-line treatment of pemphigus , 2017, The Lancet.

[15]  O. Dereure,et al.  First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial , 2017, The Lancet.

[16]  A. Capucci,et al.  Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study , 2017, The Journal of Rheumatology.

[17]  Sanjiv J. Shah,et al.  A Test in Context: E/A and E/e' to Assess Diastolic Dysfunction and LV Filling Pressure. , 2017, Journal of the American College of Cardiology.

[18]  K. Addetia,et al.  Reproducibility and experience dependence of echocardiographic indices of left ventricular function: Side‐by‐side comparison of global longitudinal strain and ejection fraction , 2017, Echocardiography.

[19]  Katrina L. Randall.  Rituximab in autoimmune diseases. , 2016, Australian prescriber.

[20]  T. Denney,et al.  Diagnostic Accuracy of Tissue Doppler Index E/è for Evaluating Left Ventricular Filling Pressure and Diastolic Dysfunction/Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta‐Analysis , 2016, Journal of the American Heart Association.

[21]  Paaladinesh Thavendiranathan,et al.  Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. , 2014, Journal of the American College of Cardiology.

[22]  M. Nurmohamed,et al.  Myocardial infarction after rituximab treatment for rheumatoid arthritis: Is there a link? , 2014, Current pharmaceutical design.

[23]  M. Francone,et al.  Global and regional longitudinal strain assessed by two-dimensional speckle tracking echocardiography identifies early myocardial dysfunction and transmural extent of myocardial scar in patients with acute ST elevation myocardial infarction and relatively preserved LV function. , 2013, European heart journal cardiovascular Imaging.

[24]  Mario J. Garcia,et al.  RITUXIMAB AND CARDIOTOXICIY , 2013 .

[25]  M. Meurer,et al.  Efficacy and safety of rituximab in pemphigus: experience of the German Registry of Autoimmune Diseases , 2012, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[26]  F. Breedveld,et al.  Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis , 2011, Annals of the rheumatic diseases.

[27]  R. Corona,et al.  Treatment of severe pemphigus with rituximab: report of 12 cases and a review of the literature. , 2007, Archives of dermatology.

[28]  A. Ahmed,et al.  Rituximab: a monoclonal antibody to CD20 used in the treatment of pemphigus vulgaris. , 2006, Journal of the American Academy of Dermatology.

[29]  M. Asaka,et al.  Delayed Reduction in Left Ventricular Function following Treatment of Non-Hodgkin’s Lymphoma with Chemotherapy and Rituximab, Unrelated to Acute Infusion Reaction , 2006, Cardiology.

[30]  K. Mitani,et al.  Ventricular tachycardia associated with infusion of rituximab in mantle cell lymphoma , 2005, American journal of hematology.

[31]  P. Lysyansky,et al.  Global longitudinal strain: a novel index of left ventricular systolic function. , 2004, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[32]  B. Coiffier.  Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphoma. , 2002, Seminars in oncology.

[33]  C. McKean.  Figures , 1970, Five Long Winters.

[34]  T. Kuwahara,et al.  Reversible Atrial Fibrillation with Bradycardia Associated with Primary Cardiac B-Cell Lymphoma. , 2016, Internal medicine.

[35]  Pierre Morel,et al.  CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. , 2002, The New England journal of medicine.